Crossmark

Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future

Crossref DOI link: https://doi.org/10.1038/s41585-022-00638-6

Published Online: 2022-08-16

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Van Poppel, Hendrik https://orcid.org/0000-0002-7458-8578
Albreht, Tit https://orcid.org/0000-0002-1812-4381
Basu, Partha https://orcid.org/0000-0003-0124-4050
Hogenhout, Renée https://orcid.org/0000-0002-8263-9507
Collen, Sarah https://orcid.org/0000-0002-8407-4511
Roobol, Monique https://orcid.org/0000-0001-6967-1708
License Information

Text and Data Mining valid from 2022-08-16

Version of Record valid from 2022-08-16
More Information

Article History

Accepted: 14 July 2022

First Online: 16 August 2022

Competing interests

: The authors declare no competing interests.